Sample results
Metastatic liver cancer occurs when cancer cells from other parts of the body spread to the liver through the bloodstream or lymphatic system. It is caused by primary cancers from organs such as the colon, pancreas, breast, or lung that metastasize to liver tissue. The Alpha-Fetoprotein (AFP) Serum Tumor Marker test is the most important blood test for monitoring metastatic liver cancer because it tracks tumor activity and treatment response.
Metastatic liver cancer is caused by cancer cells that break away from primary tumors in other organs and travel through the bloodstream or lymphatic system to the liver. The most common primary cancers that metastasize to the liver include colorectal cancer, pancreatic cancer, breast cancer, lung cancer, and stomach cancer. The liver's role in filtering blood makes it particularly susceptible to receiving cancer cells from other parts of the body, and its rich blood supply creates an environment where these metastatic cells can grow and form new tumors.
The Alpha-Fetoprotein (AFP) Serum Tumor Marker test is the most important blood test for metastatic liver cancer because it detects elevated levels of AFP protein that tumor cells often produce when cancer spreads to the liver. This test is essential for monitoring disease progression and assessing how well treatment is working over time. While imaging studies like CT scans or MRIs are needed to visualize liver metastases, AFP testing provides valuable ongoing monitoring of tumor activity and can detect changes in cancer status before they appear on imaging. Regular AFP monitoring helps healthcare providers make timely adjustments to treatment plans and track whether therapy is effectively controlling cancer growth.
You should get tested if you have been diagnosed with primary cancer in another organ and are experiencing symptoms like unexplained weight loss, persistent abdominal pain or swelling, loss of appetite, jaundice (yellowing of skin or eyes), or unusual fatigue. Patients with a history of colorectal, pancreatic, breast, or lung cancer should have regular AFP testing as part of their surveillance protocol, even without symptoms. If you notice new or worsening abdominal discomfort, changes in digestion, or if your primary cancer was known to commonly spread to the liver, immediate testing is important for early detection and treatment planning.
What this means
Your AFP level is slightly elevated above the normal range for healthy adults. While this could indicate early tumor activity in the liver or testicles, it can also be elevated in non-cancerous conditions like hepatitis or cirrhosis. Your doctor will likely recommend additional imaging or tests to determine the cause.
Recommended actions
Schedule a follow-up appointment with your doctor to discuss results and next steps
Your doctor may order imaging tests such as ultrasound, CT scan, or MRI
Avoid alcohol if you have liver disease, as it can worsen liver damage
Retest AFP in 4-8 weeks to monitor trends, or sooner if recommended by your physician
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: